Summary
At any age hypnotic drug use can give rise to 3 major problems: unwanted effects on daytime mood and behaviour associated with drug consumption; rebound effects associated with drug withdrawal; and dependency associated with long term drug use. For 2 reasons elderly hypnotic users are both more vulnerable and more exposed to each of these problems. Firstly, age-related changes in pharmacodynamic and pharmacokinetic processes amplify the behavioural impact of many hypnotics; and secondly, age-related changes in the structure and quality of sleep tend to increase the demand for, and the long term use of, sedative hypnotic compounds in old age. The existence of physical illness, cognitive impairment, or daytime behaviour already compromised by normal aging processes further increases the likelihood of hypnotic drugs detrimentally affecting well-being in later life.
These important causes for concern emphasise the need for 2 separate clinical responses: the need for greater circumspection in the choice and use of hypnotic drugs among elderly patients, and the need for a more broadly based clinical approach to the management of sleep problems in old age.
Similar content being viewed by others
References
Adam K, Adamson L, Brezinova V, Hunter WM, Oswald I. Nitrazepam: lastingly effective but trouble on withdrawal. British Medical Journal 1: 1558–1560, 1976
Adam K, Oswald I. Can a rapidly eliminated hypnotic cause daytime anxiety? Pharmacopsychiatry 22: 115–119, 1989
Adam K, Oswald I, Shapiro C. Effects of loprazolam and triazolam on sleep and overnight urinary cortisol. Psychopharmacology 82: 389–394, 1984
Ancoli-Israel S, Kripke DF, Mason W, Kaplan OJ. Sleep apnea and periodic movements in an aging sample. Journal of Gerontology 40: 419–425, 1985
Ashton H. Benzodiazepine withdrawal: an unfinished story. British Medical Journal 288: 1135–1140, 1984
Bliwise DL, Feldman DE, Bliwise NG, Carskadon MA, Kraemer HC, et al. Risk factors for sleep disordered breathing in heterogeneous geriatric populations. Journal of the American Geriatrics Society 35: 132–141, 1987
Briggs RS, Castleden CM, Kraft CA. Improved hypnotic treatment using chlormethiazole and temazepam. British Medical Journal 1: 601–604, 1980
Buck JA. Psychotropic drug practice in nursing homes. Journal of the American Geriatrics Society 36: 409–418, 1988
Castleden CM, George CF, Marcer D, Hallett C. Increased sensitivity to nitrazepam in old age. British Medical Journal 1: 10–12, 1977
Clark TJH, Collins JV, Tong D. Respiratory depression caused nitrazepam in patients with respiratory failure. Lancet 2: 737–738, 1971
Coleman RM, Miles LE, Guilleminault CC, Zarcone VP, van den Hoed J, et al. Sleep-wake disorders in the elderly: a polysomnographic analysis. Journal of the American Geriatrics Society 29: 289–296, 1981
Committee on the Review of Medicines. Systematic review of the benzodiazepines. British Medical Journal 1: 910–912, 1980
Cook PJ. Benzodiazepines in the elderly. Acta Psychiatrica Scandinavica 74 (Suppl. 332): 149–158, 1986
Cook PJ, Huggett A, Graham-Pole R, Savage IT, James IA. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. British Medical Journal 286: 100–102, 1983
Department of Health. Health and personal social service statistics for England, HMSO, London, 1989
Dolly FR, Block AJ. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. American Journal of Medicine 73: 239–243, 1982
Dunbar GC, Perera MH, Jenner FA. Patterns of benzodiazepine use in Great Britain as measured by a general population survey. British Journal of Psychiatry 155: 836–841, 1989
Dunnell K, Cartwright A. Medicine takers, prescribers and hoarders, Routledge and Keegan, London, 1972
Evans JG, Jarvis EH. Nitrazepam and the elderly. British Medical Journal 4: 487, 1972
Fruensgaard K. Withdrawal psychosis: a study of 30 consecutive cases. Acta Psychiatrica Scandinavica 53: 105–118, 1976
Gaillot J, Heusse D, Houghton G, Aurele J-M, Dreyfus J. Pharmacokinetics and metabolism of zopiclone. Pharmacology 27 (Suppl. 2): 76–91, 1983
Goa KL, Heel RC. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as a hypnotic. Drugs 32: 48–65, 1986
Greenblatt DJ, Allen MD. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. British Journal of Clinical Pharmacology 5: 407–413, 1978
Greenblatt DJ, Allen MD, Shader RI. Toxicity of high-dose flurazepam in the elderly. Clinical Pharmacology and Therapeutics 21: 355–361, 1977
Hicks R, Dysken MW, Davis JM, Lesser J, Ripeckyj A, et al. The pharmacokinetics of psychotropic drugs in the elderly: a review. Journal of Clinical Psychiatry 42: 374–385, 1981
Houghton G, Dennis M, Templeton R, Martin B. A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane®). International Journal of Clinical Pharmacology, Therapy and Toxicology 23: 97–100, 1985
Ingman SR, Lawson IR, Pierpaoli PG, Blake P. A survey of the prescribing and administration of drugs in a long-term care institution for the elderly. Journal of the American Geriatrics Society 7: 309–316, 1975
Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, et al. Quazepam and flurazepam: long-term use and extended withdrawal. Clinical Pharmacology and Therapeutics 32: 781–788, 1982
Kales A, Soldatos CR, Bixler EO, Kales JD. Early morning insomnia with rapidly eliminated benzodiazepines. Science 220: 95–97, 1983
Karacan I, Thornby JI, Anch M, Holzer CE, Warheit GJ, et al. Prevalence of sleep disturbance in a primarily urban Florida county. Social Science and Medicine 10: 239–244, 1976
Klimm HD, Dreyfus JF, Delmotte M. Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 10 (Suppl.): 73–78, 1987
Kripke DF, Garfinkel L. Excess nocturnal deaths related to sleeping pill and tranquilliser use. Lancet 1: 99, 1984
Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills: is increased mortality associated? Archives of General Psychiatry 36: 103–116, 1979
Lader M. The use and abuse of hypnotics. In Home & Page (Eds) Sleep disorders, pp. 1–8, Duphar Medical Relations, Southampton, 1989
Lion JR, Azcarate C, Koepke HH. ‘Paradoxical rage reactions’ during psychotropic mediation. Diseases of the Nervous System 36: 557–558, 1975
Mellinger GD, Balter MB, Chase C, Manheimer DI. Patterns of psychotherapeutic drug use among adults in San Francisco. Archives of General Psychiatry 25: 385–397, 1971
Model DG, Berry DJ. Effects of chlordiazepoxide in respiratory failure due to chronic bronchitis. Lancet 2: 869–870, 1974
Morgan K. Effects of repeated dose nitrazepam and lormetazepam on psychomotor performance in the elderly. Psychopharmacology 86: 209–211, 1985
Morgan K. Trends in hypnotic drug usage among elderly people. Abstract. Human Psychopharmacology Clinical and Experimental 5: 72–73, 1990
Morgan K, Adam K, Oswald I. Effects of loprazolam and triazolam on psychological functions. Psychopharmacology 82: 386–388, 1984
Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. British Medical Journal 296, 601–602, 1988
Morgan K, Gilleard CJ, Reive A. Hypnotic usage in residential homes for the elderly: a prevalence and longitudinal analysis. Age and Ageing 11: 229–234, 1982
Morgan K, Oswald I. Anxiety caused by a short-life hypnotic. British Medical Journal 284: 942, 1982
Morgan K, Tomeny M. Benzodiazepine withdrawal and rebound insomnia. Acta Psychiatrica Scandinavica 80: 297–298, 1989
Murray J, Dunn G, Williams P, Tarnapolsky A. Factors affecting the consumption of psychotropic drugs. Psychological Medicine 11: 551–560, 1981
Oswald I, Adam K, Borrow S, Idzikowski C. The effects of two hypnotics on sleep, subjective feelings and skilled performance. In Passouant & Oswald (Eds) Pharmacology of the states of alertness, pp. 51–63, Pergamon, Oxford, 1979
Parker G, Roberts C. Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease. British Journal of Clinical Pharmacology 16: 259–265, 1983
Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. British Medical Journal 283: 643–645, 1984
Ray WR, Federspiel CF, Shaffner W. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. American Journal of Public Health 70: 485–491, 1980
Ray WR, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363–369, 1987
Rigby J, Harvey M, Davies DR. Mania precipitated by benzodiazepine withdrawal. Acta Psychiatrica Scandinavica 79: 406–407, 1989
Rodrigo EK, King MB, Williams P. Health of long term benzodiazepine users. British Medical Journal 296: 603–606, 1988
Salzman C Kochansky GE, Shader RI, Porrino LJ, Harmatz JS, et al. Chlordiazepoxide-induced hostility in a small group setting. Archives of General Psychiatry 31: 401–405, 1974
Salzman C, Van der Kolk B. Psychotropic drug prescriptions for elderly patients in a general hospital. Journal of the American Geriatrics Society 28: 18–22, 1980
Schneider-Helmert D. Why low-dose benzodiazepine-dependent insomniacs can’t escape their sleeping pills. Acta Psychiatrica Scandinavica 78: 706–711, 1989
Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J. Side-effect ‘tolerance’ in elderly long-term recipients of benzodiazepine hypnotics. Age and Ageing 13: 335–343, 1984
Viukari M, Linnoila M, Halto U. Efficacy and side effects of flurazepam, and nitrazepam as sleeping aids in psychogeriatric patients. Acta Psychiatrica Scandinavica 57: 27–35, 1978
Weedle PB, Poston JW, Parish PA. Use of hypnotic medicines by elderly people in residential homes. Journal of the Royal College of General Practitioners 38: 156–158, 1988
Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age and Ageing 9: 73–80, 1980
Woods HW, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacological Reviews 39: 251–413, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morgan, K. Hypnotics in the Elderly. Drugs 40, 688–696 (1990). https://doi.org/10.2165/00003495-199040050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199040050-00004